UK Chanel 4 Investigates: The Drug Trial That Went Wrong_Critique NEJM Editorial

“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of  TGN1412, a monoclonal antibody drug, conducted in March 2006 at London’s Northwick Park Hospital. [1]  It airs momorrow. Continue reading →

British Rethinking Rules After Ill-Fated Drug Trial_NYT

A front page report in The New York Times provides additonal information about the catastrophic TGN1412 medical experiment in which 6 previously healthy volunteers were intravenously injected with monoclonal antibody in a highly risky procedure.
Continue reading →

London Drug Trial Catastrophe: Collapse of Science and Ethics

The independent Institute of Science in Society (ISIS) challenges the report issued by the UK government medicines oversight agency, MHRA (equivalent to US FDA), absolving itself and those involved from any responsibility for a catastrophic human experiment that nearly killed six healthy volunteers.
Continue reading →

Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow

Unless Congress acts to overrule the FDA, research disasters such as occurred in London, when six healthy men were exposed to an experimental substance that brought them close to death, are likely to occur with increased frequency. Continue reading →

Guinea Pig Gang: Meet U.S. Students Who Rent Their Bodies for Cash

A series of news reports may be a rude awakening to the fact that there are hidden, potentially lethal hazards of participating in clinical trials—and those hazards are concealed from the human guinea pigs who are enticed with promise of easy money. Continue reading →

Mercury Crimes at CDC

"It’s time for the CDC to come clean with the American public. Its tactics of deception and obfuscation are jeopardizing the credibility of the entire vaccine program, and therefore posing an enormous danger to public health." Robert Kennedy, Jr. See letter to FDA Commissioner.
Continue reading →

FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug

“When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease. Last year, she died at the age of 46 from an infection linked to the drug.”

Continue reading →